Research estimates the changing burden of COVID-19 in Austin, Texas Austin Texas Research Coronavirus Disease COVID universityofga UTAustin LosAlamosNatLab TACC RockefellerFdn sfi_news
COVID-19 has profoundly but disproportionately affected individuals depending on their residence and workplace location, socioeconomic status, and ethnicity. Studies have reported catastrophic discrepancies at several time points of the pandemic, the severity of which has not yet been tracked systematically.
ZIP codes ranking in the 25th and 75th percentiles of vulnerability were compared. The daily counts of SARS-CoV-2 infections, stratified by age for every ZIP code in Austin, were estimated. Hospital admission data was provided by three main public health systems of Austin. First, the age-stratified IHRs from statewide COVID-19 hospital admission data and data of SARS-CoV-2 seroprevalence were estimated.
Results The period of the study preceded the SARS-CoV-2 Delta VOC emergence, including a pandemic wave during April 2020 and larger subsequent COVID-19 waves in summer and winter . Among the waves, the summer COVID-19 wave was relatively mild for children. By 1 June 2021, 83,722 cases were reported, including 6,474 and 1,024 hospitalized and deceased COVID-19 patients in the county, from a population of 1.3 million.
Six percent of all SARS-CoV-2 infections between 1 March and 1 May 2020 were observed among children, who comprised 20% of the total population, compared to 20% of infections between 1 December 2020 and 1 February of the consecutive year. The number of SARS-CoV-2 infections among individuals aged 18 to 49, who comprised 51% of the total population, reduced from 69% during spring 2020 to 51% during the 2020-2021 winter COVID-19 wave.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Vaccine confidence 'another victim of the COVID-19 pandemic', study findsResearchers found a fall in confidence in nearly one in four participants since 2020, regardless of their age, gender, religious belief, education or ethnicity.
Read more »
COVID-19 amplifies damage to the central nervous system in Alzheimer's diseaseCOVID-19 amplifies damage to the central nervous system in Alzheimer's disease Alzheimers Disease CentralNervousSystem CNS Coronavirus COVID Encephalitis Endothelialitis SpikeProtein Microvasculature ElsevierNews GnomeDx OhioState RutgersU
Read more »
Multinational consensus to end COVID-19 pandemicMultinational consensus to end COVID-19 pandemic NaturePortfolio UniBarcelona Pandemic COVID19 SARSCoV2
Read more »
Cholesterol medication fenofibrate fails to cut severe symptoms or death in COVID-19 patientsAfter showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists. The study results were presented Monday at the American Heart Association's Scientific Sessions 2022 and published in the journal Nature Metabolism.
Read more »